Literature DB >> 9631336

Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures.

E M Tuomola1, S J Salminen.   

Abstract

The adhesion of 12 different Lactobacillus strains was studied using Caco-2 cell line as an in vitro model for intestinal epithelium. Some of the strains tested have been used as probiotics, and most of them are used in the dairy and food industry. Human and bovine enterotoxigenic Escherichia coli strains were used as positive and negative control, respectively. Bacterial adhesion to Caco-2 cell cultures was quantitated using radiolabelled bacteria. The adherence of bacteria was also observed microscopically after Gram staining. Viability of bacteria prior to adhesion was verified using flow cytometry. Among the tested strains, L. casei (Fyos) was the most adhesive strain and L. casei var. rhamnosus (Lactophilus) was the least adhesive strain, approximately 14 and 3% of the added bacteria adhered to Caco-2 cell cultures, respectively. The corresponding values for positive and negative control E. coli strains were 14 and 4%, respectively. The Lactobacillus strains tested could not be divided into distinctly adhesive or non-adhesive strains, since there was a continuation of adhesion rates. The four most adhesive strains were L. casei (Fyos), L. acidophilus 1 (LC1), L. rhamnosus LC-705 and Lactobacillus GG (ATCC 53103). No significant differences in the percentage adhesion were observed between these strains. Adhesion of all the strains was dependent on the number of bacteria used, since an approximately constant number of Caco-2 cells was used, indicating that the Caco-2 cell binding sites were not saturated. Viability of bacteria was high since approximately 90% of the bacteria were viable with the exception of L. acidophilus 1 which was 74% viable. Microscopic evaluations agreed with the radiolabelled binding as evidenced by observing more bacteria in Gram-stained preparations of good adhering strains compared to poorly adhering strains.

Entities:  

Mesh:

Year:  1998        PMID: 9631336     DOI: 10.1016/s0168-1605(98)00033-6

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  70 in total

1.  Probiotics in the Treatment of Diarrheal Diseases.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria.

Authors:  Arthur C Ouwehand; Seppo Salminen; Satu Tölkkö; Peter Roberts; Jari Ovaska; Eeva Salminen
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

Review 3.  Probiotics and immune response.

Authors:  Stephanie Blum; Dirk Haller; Andrea Pfeifer; Eduardo J Schiffrin
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

4.  In vitro adhesion and platelet aggregation properties of bacteremia-associated lactobacilli.

Authors:  P V Kirjavainen; E M Tuomola; R G Crittenden; A C Ouwehand; D W Harty; L F Morris; H Rautelin; M J Playne; D C Donohue; S J Salminen
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection.

Authors:  T Asahara; K Nomoto; M Watanuki; T Yokokura
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

6.  Is Pseudobutyrivibrio xylanivorans strain Mz5T suitable as a probiotic? An in vitro study.

Authors:  T Cepeljnik; M Zorec; R Kostanjsek; F V Nekrep; R Marinsek-Logar
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

7.  Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits.

Authors:  Ingemar von Ossowski; Justus Reunanen; Reetta Satokari; Satu Vesterlund; Matti Kankainen; Heikki Huhtinen; Soile Tynkkynen; Seppo Salminen; Willem M de Vos; Airi Palva
Journal:  Appl Environ Microbiol       Date:  2010-01-29       Impact factor: 4.792

8.  Expression of fluorescent proteins in bifidobacteria for analysis of host-microbe interactions.

Authors:  Verena Grimm; Marita Gleinser; Caroline Neu; Daria Zhurina; Christian U Riedel
Journal:  Appl Environ Microbiol       Date:  2014-02-28       Impact factor: 4.792

Review 9.  The role of probiotics in management of irritable bowel syndrome.

Authors:  Anna M Borowiec; Richard N Fedorak
Journal:  Curr Gastroenterol Rep       Date:  2007-10

10.  Probiotics and small bowel mucosa: Molecular aspects of their interactions.

Authors:  N Saulnier; M A Zocco; S Di Caro; G Gasbarrini; A Gasbarrini
Journal:  Genes Nutr       Date:  2006-06       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.